| Mrs Yvette Gozzo, MD | |
|
320 Superior Ave Ste 200, Newport Beach, CA 92663-2741 | |
| (949) 642-6200 | |
| Not Available |
| Full Name | Mrs Yvette Gozzo |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 25 Years |
| Location | 320 Superior Ave Ste 200, Newport Beach, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952351066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MA74996 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
| Entity Name | Yvette M. Gozzo, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366939373 PECOS PAC ID: 0547524241 Enrollment ID: O20180504001159 |
News Archive
Amgen today announced pooled data from two pivotal Phase 3, global, randomized, placebo-controlled trials evaluating AMG 416, a novel calcimimetic, for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving hemodialysis.
Gender-affirming hormone therapy is the bedrock of medical therapy for many transgender and gender diverse individuals. Some adult transgender individuals decide with their health care provider to start hormone therapy – testosterone for transmasculine people and generally a combination of estrogen and antiandrogens for transfeminine people – specifically for the physical and psychological effects these hormones produce, including changes to the voice, skin, facial and body hair and body composition. However, in the context of the global obesity epidemic, little is known about obesity rates and weight changes in adults treated with gender-affirming hormone therapy.
Acupuncture, when used as a complementary or adjuvant therapy for in vitro fertilization (IVF), may be beneficial depending on the baseline pregnancy rates of a fertility clinic, according to research from the University of Maryland School of Medicine. The analysis from the University of Maryland Center for Integrative Medicine is published in the June 27 online edition of the journal Human Reproduction Update.
Institute for Basic Science (IBS), the main organization of the International Science and Business Belt project in South Korea, has announced that a group of researchers, led by professor Won Do Heo, have developed a new technology in the field of optogenetics that can remotely control specific receptors by light.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Yvette Gozzo, MD 320 Superior Ave Ste 200, Newport Beach, CA 92663-2741 Ph: (949) 642-6200 | Mrs Yvette Gozzo, MD 320 Superior Ave Ste 200, Newport Beach, CA 92663-2741 Ph: (949) 642-6200 |
News Archive
Amgen today announced pooled data from two pivotal Phase 3, global, randomized, placebo-controlled trials evaluating AMG 416, a novel calcimimetic, for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving hemodialysis.
Gender-affirming hormone therapy is the bedrock of medical therapy for many transgender and gender diverse individuals. Some adult transgender individuals decide with their health care provider to start hormone therapy – testosterone for transmasculine people and generally a combination of estrogen and antiandrogens for transfeminine people – specifically for the physical and psychological effects these hormones produce, including changes to the voice, skin, facial and body hair and body composition. However, in the context of the global obesity epidemic, little is known about obesity rates and weight changes in adults treated with gender-affirming hormone therapy.
Acupuncture, when used as a complementary or adjuvant therapy for in vitro fertilization (IVF), may be beneficial depending on the baseline pregnancy rates of a fertility clinic, according to research from the University of Maryland School of Medicine. The analysis from the University of Maryland Center for Integrative Medicine is published in the June 27 online edition of the journal Human Reproduction Update.
Institute for Basic Science (IBS), the main organization of the International Science and Business Belt project in South Korea, has announced that a group of researchers, led by professor Won Do Heo, have developed a new technology in the field of optogenetics that can remotely control specific receptors by light.
› Verified 7 days ago
Dr. Sevitlana Safaei, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Superior Ave, Ste 205, Newport Beach, CA 92663 Phone: 949-650-2462 Fax: 949-650-1366 | |
Dr. Jin-hwa Simon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Brian Kong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Dr. Cesar Balbin Guerrero, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 350 Vista Madera, Newport Beach, CA 92660 Phone: 949-270-6371 | |
Nhat Tran, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Dr. Leslie Kennerly Meserve, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Newport Center Dr Ste 310, Newport Beach, CA 92660 Phone: 949-558-0501 Fax: 949-558-0502 | |
Bhavini Jashvant Jaiswal, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Critical Care Department Box 6100, Newport Beach, CA 92663 Phone: 480-227-1318 |